Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC) Meeting Abstract


Authors: Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; Moynahan, M. E.; Fusco, A.; Stadler, Z. K.; Do, K. G.; Chen, A. P.; Yu, K. H.; Tang, L. H.; O'Reilly, E. M.
Abstract Title: Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
Meeting Title: 2015 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 3 Suppl.
Meeting Dates: 2015 Jan 15-17
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-01-20
Language: English
ACCESSION: WOS:000356883800356
PROVIDER: wos
DOI: 10.1200/jco.2015.33.3_suppl.358
Notes: Meeting Abstract: 358 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary Ellen Moynahan
    105 Moynahan
  2. Zsofia Kinga Stadler
    387 Stadler
  3. Marinela Capanu
    385 Capanu
  4. Maeve Aine Lowery
    133 Lowery
  5. Kenneth Ho-Ming Yu
    163 Yu
  6. Kinh Gian Do
    256 Do
  7. Laura Hong Tang
    447 Tang
  8. Eileen O'Reilly
    780 O'Reilly
  9. David P Kelsen
    537 Kelsen
  10. Malcolm A S Moore
    549 Moore
  11. Anne Fusco
    5 Fusco
  12. Sloane Camille Baptiste Smith
    6 Smith